Klobuchar signed onto 2017 letter to President Trump, asking him to follow the recommendations of his Commission on Combating Drug Addiction and the Opioid Crisis and allow the government to negotiate lower prices for naloxone.
In December, 2018, Minnesota Senators Amy Klobuchar and Tina Smith sent a letter to the U.S. Department of Human Services asking them to take action to reduce the price of naloxone. 15 additional senators signed on.
“Of course this drug saves lives. We all know that. What they are forgetting to say is how they are making a ton of money over how they classified this product. They basically found a loophole and exploited it and that is just what happened with EpiPen. So it is our job to close the loophole.”
Minnesota Senators push to lower cost of Naloxone to help fight opioid epidemic
Klobuchar.senate.gov, December 7, 2018 | Leah Mclean
From the 2018 letter to the HHS director, sent by 17 senators: “No police officer, no firefighter, no public health provider, and no person should be unable to save a life because of the high price,” the lawmakers wrote.“By bringing down the cost, we can get this life-saving drug in the hands of more people as called for by the Surgeon General. Doing so will save countless lives.”
Klobuchar, Smith, Senators Call on Administration to Take Immediate Action to Reduce Price of Naloxone, a Life-Saving Opioid Overdose Reversal Drug
Klobuchar Senate Website, April 30, 2018
Read More
Blumenthal, Murphy Call on President To Allow Government to Negotiate Lower Prices for Naloxone, a Life-Saving Opioid Overdose Reversal Drug
Office of Senator Richard Blumenthal, October 25, 2017
Klobuchar, Smith, Senators Call on Administration to Take Immediate Action to Reduce Price of Naloxone, a Life-Saving Opioid Overdose Reversal Drug
Klobuchar Senate Website, April 30, 2018
